Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cbiz (CBZ) Cash from Financing Activities (2016 - 2025)

Cbiz (CBZ) has disclosed Cash from Financing Activities for 16 consecutive years, with -$70.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 106.29% year-over-year to -$70.5 million, compared with a TTM value of -$145.7 million through Dec 2025, down 114.07%, and an annual FY2025 reading of -$145.7 million, down 114.07% over the prior year.
  • Cash from Financing Activities was -$70.5 million for Q4 2025 at Cbiz, down from -$42.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.1 billion in Q4 2024 and bottomed at -$88.6 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is $36.3 million, with a median of -$40.1 million recorded in 2023.
  • The sharpest move saw Cash from Financing Activities plummeted 505.08% in 2021, then soared 5858.31% in 2022.
  • Year by year, Cash from Financing Activities stood at -$70.7 million in 2021, then surged by 66.94% to -$23.4 million in 2022, then tumbled by 151.07% to -$58.7 million in 2023, then soared by 2010.44% to $1.1 billion in 2024, then crashed by 106.29% to -$70.5 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CBZ at -$70.5 million in Q4 2025, -$42.0 million in Q3 2025, and -$88.6 million in Q2 2025.